57TiP "PRIME Study: Searching for immune biomarkers in advanced castration resistant prostate cancer (CRPC) patients treated with standard therapy
N Romero-Laorden, A Zapatero, L San Jose… - Annals of Oncology, 2018
… In both p16 positive and negative stomatitis (p ¼ 0.75) was the most common adverse
event. Oral stomatitis of Grade 1&2 (100% in p16 þve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16þ and 49.20% in p16_ patients) …
event. Oral stomatitis of Grade 1&2 (100% in p16 þve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16þ and 49.20% in p16_ patients) …
 |  |  |
56PQuantification BCL6 tissue expression using FISH and immunohistochemistry in diffuse large B-cell lymphoma by digital image analysis
V Kushnarev, N Matyashina - Annals of Oncology, 2018
… In both p16 positive and negative stomatitis (p ¼ 0.75) was the most common adverse
event. Oral stomatitis of Grade 1&2 (100% in p16 þve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16þ and 49.20% in p16_ patients) …
event. Oral stomatitis of Grade 1&2 (100% in p16 þve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16þ and 49.20% in p16_ patients) …
| | |
54PImpact of HPV DNA and p16 on radical chemo-radiotherapy response in oropharyngeal cancer patients
P Yadav, N Kumar, S Beniwal - Annals of Oncology, 2018
… In both p16 positive and negative stomatitis (p = 0.75) was the most common adverse
event. Oral stomatitis of Grade 1&2 (100% in p16 +ve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16+ and 49.20% in p16_ patients) …
event. Oral stomatitis of Grade 1&2 (100% in p16 +ve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16+ and 49.20% in p16_ patients) …
| | |
55PTP53 mutations as predictor of response and longer survival under immune checkpoint inhibitors in advanced non-small cell lung cancer
S Assoun, N Theou-Anton, M Nguenang, A Cazes… - Annals of Oncology, 2018
… In both p16 positive and negative stomatitis (p ¼ 0.75) was the most common adverse
event. Oral stomatitis of Grade 1&2 (100% in p16 þve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16þ and 49.20% in p16_ patients) …
event. Oral stomatitis of Grade 1&2 (100% in p16 þve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16þ and 49.20% in p16_ patients) …
| | |
[PDF] Effect of Herbal Echinacea on Recurrent Minor Oral Aphthous Ulcer
F Khozeimeh, Z Saberi, A Tavangar, FF Badi - The Open Dentistry Journal, 2018
… Practical aspects of management of recurrent aphthous stomatitis. J …
[https://ift.tt/2OGURv5] [PMID: 17714120]
[3] Hudson J. Recurrent aphthous stomatitis: Diagnosis and management …
[https://ift.tt/2OGURv5] [PMID: 17714120]
[3] Hudson J. Recurrent aphthous stomatitis: Diagnosis and management …
| | |
Mannoside Glycolipid Conjugates Display Antiviral Activity Against Ebola Virus
O Reynard, E Schaeffer, VA Volchkova, A Cimarelli… - The Journal of Infectious …, 2018
… Experiments using live EBOV were performed in the Jean Merieux biosafety level
4 INSERM laboratory (Lyon, France). Generation of vesicular stomatitis virus (VSV)
replicon pseudo- types have been described previously [15] …
4 INSERM laboratory (Lyon, France). Generation of vesicular stomatitis virus (VSV)
replicon pseudo- types have been described previously [15] …
| | |
[HTML] Molecular Discrimination of the Candida parapsilosis Species Complex via SADH Gene Analysis and Evaluation of Proteinase Activity Among the Isolates
K Pakshir, F Karimi, K Zomorodian, S Ansari, H Nouraei… - Jundishapur Journal of …, 2018
… Extracellular aspartyl proteinase (Sap) is a putative virulence factor in Candida
species (8). In our previous study, Candida species were isolated from onychomycosis
and oral lesions of diabetic and denture stomatitis patients …
species (8). In our previous study, Candida species were isolated from onychomycosis
and oral lesions of diabetic and denture stomatitis patients …
| | |
53PmiR-4317, a promising player tuning the anti-tumor armamentarium against breast cancer
RA Youness, RA Assal, A Abdelmotaal, MZ Gad - Annals of Oncology, 2018
… In both p16 positive and negative stomatitis (p = 0.75) was the most common adverse
event. Oral stomatitis of Grade 1&2 (100% in p16 +ve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16+ and 49.20% in p16_ patients) …
event. Oral stomatitis of Grade 1&2 (100% in p16 +ve and 96.8% in p16 -ve patients)
and grade 3&4 (58.8% in p16+ and 49.20% in p16_ patients) …
| | |
Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative …
M Campone, SA Im, H Iwata, M Clemons, Y Ito… - European Journal of Cancer, 2018
… for hyperglycemia (43% versus 8%), elevated ALT (40% versus 7%), nausea
(40% versus 24%), elevated AST (38% versus 10%), diarrhoea (35% versus
15%), fatigue (33% versus 25%), rash (33% versus 7%), decreased appetite …
(40% versus 24%), elevated AST (38% versus 10%), diarrhoea (35% versus
15%), fatigue (33% versus 25%), rash (33% versus 7%), decreased appetite …
| | |
Interdisziplinäre Therapie von Knochenmetastasen
J Fakler, T Todenhöfer, M Müller, AA Kurth… - Fortbildung Osteologie 4, 2018
… senken konnte (Gnant et al. 2013). Die häufigste Nebenwirkung von Everolimus
ist eine Stomatitis (40%). Das Risiko einer Pneumonitis wird mit 8% angegeben
(Motzer et al. 2008). Ende 2013 wurde das Radiopharmakon …
ist eine Stomatitis (40%). Das Risiko einer Pneumonitis wird mit 8% angegeben
(Motzer et al. 2008). Ende 2013 wurde das Radiopharmakon …
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου